RESUMEN
Microglia cells (MGCs) play a key role in scavenging pathogens and phagocytosing cellular debris in the central nervous system and retina. Their activation, however, contributes to the progression of multiple degenerative diseases. Given the potential damage created by MGCs, it is important to better understand their mechanism of activation. Here, we explored the role of MGCs in the context of retinitis pigmentosa (RP) by using four independent preclinical mouse models. For therapeutic modeling, tamoxifen-inducible CreER was introduced to explore changes in MGCs when RP progression halted. The phenotypes of the MGCs were observed using live optical coherence tomography, live autofluorescence, and immunohistochemistry. We found that, regardless of genetic background, MGCs were activated in neurodegenerative conditions and migrated beyond the layers where they are typically found to the inner and outer segments, where degeneration was ongoing. Genetic rescue not only halted degeneration but also deactivated MGCs, regardless of whether the intervention occurred at the early, middle, or late stage of the disease. These findings suggest that halting long-term disease progression may be more successful by downregulating MGC activity while co-administering the therapeutic intervention.
Asunto(s)
Microglía/patología , Hidrolasas Diéster Fosfóricas/genética , Retinitis Pigmentosa/diagnóstico por imagen , Tamoxifeno/farmacología , Animales , Receptor 1 de Quimiocinas CX3C/metabolismo , Modelos Animales de Enfermedad , Terapia Genética , Humanos , Ratones , Hidrolasas Diéster Fosfóricas/administración & dosificación , Retinitis Pigmentosa/genética , Retinitis Pigmentosa/metabolismo , Retinitis Pigmentosa/terapia , Tomografía de Coherencia ÓpticaRESUMEN
Diseases of ectopic calcification of the vascular wall range from lethal orphan diseases such as generalized arterial calcification of infancy (GACI), to common diseases such as hardening of the arteries associated with aging and calciphylaxis of chronic kidney disease (CKD). GACI is a lethal orphan disease in which infants calcify the internal elastic lamina of their medium and large arteries and expire of cardiac failure as neonates, while calciphylaxis of CKD is a ubiquitous vascular calcification in patients with renal failure. Both disorders are characterized by vascular Mönckeburg's sclerosis accompanied by decreased concentrations of plasma inorganic pyrophosphate (PPi). Here we demonstrate that subcutaneous administration of an ENPP1-Fc fusion protein prevents the mortality, vascular calcifications and sequela of disease in animal models of GACI, and is accompanied by a complete clinical and biomarker response. Our findings have implications for the treatment of rare and common diseases of ectopic vascular calcification.
Asunto(s)
Enfermedades del Recién Nacido/enzimología , Enfermedades del Recién Nacido/prevención & control , Hidrolasas Diéster Fosfóricas/metabolismo , Pirofosfatasas/metabolismo , Calcificación Vascular/enzimología , Calcificación Vascular/prevención & control , Animales , Arterias/enzimología , Arterias/patología , Modelos Animales de Enfermedad , Femenino , Humanos , Fragmentos Fc de Inmunoglobulinas/administración & dosificación , Fragmentos Fc de Inmunoglobulinas/genética , Fragmentos Fc de Inmunoglobulinas/metabolismo , Inmunoglobulina G/genética , Inmunoglobulina G/metabolismo , Recién Nacido , Enfermedades del Recién Nacido/genética , Enfermedades del Recién Nacido/mortalidad , Masculino , Ratones Endogámicos C57BL , Hidrolasas Diéster Fosfóricas/administración & dosificación , Hidrolasas Diéster Fosfóricas/genética , Pirofosfatasas/administración & dosificación , Pirofosfatasas/genética , Calcificación Vascular/genética , Calcificación Vascular/mortalidadRESUMEN
PURPOSE: This study was aimed to test the hypothesis that gap junction mediated communications (GJC) are required to allow the progressive chromatin configuration remodeling (from GV1 to GV3) process to occur in fully grown oocytes in order to gain the final step of developmental competence acquisition, and that a premature disruption of GJC can alter this process. METHODS: Bovine cumulus-oocytes complexes collected from medium antral follicles were cultured for 2, 4, 6 and 8 h in the presence of 10(-4) IU/ml of r-hFSH and with 2 mM of the non-selective PDE inhibitor 3-isobutyl-1-methyl-xanthine (IBMX) to prevent meiotic resumption. GJC functionality and chromatin configuration were monitored during the culture period. After meiotic arrest, the developmental capability of oocytes was assessed after IVM and IVF. RESULTS: IBMX was effective in significantly sustaining GJC up to 6 h and maintaining meiotic arrest, when compared to control group. Moreover, the percentage of oocytes with less condensed chromatin (GV1) decreased within 4 h of culture, while the proportion of GV2 oocytes gradually increased up to 6 h. Interestingly, a decline in the proportion of GV2 oocytes and an increase in the proportion of GV3 oocytes were observed after 6 h of culture, when the major drop of GJC occurred. On the contrary, when GJC were uncoupled by adding 3 mM of 1-heptanol or through cumulus cells removal, chromatin condensation occurred rapidly throughout the culture period, more promptly in denuded oocytes. Moreover, the maintenance of GJC during meiotic arrest was accompanied by a significant increase of developmental competence compared to the control, as indicated by a higher percentage of hatched blastocysts and blastocyst cell number. CONCLUSIONS: Altogether, our data indicate that both paracrine and junctional mechanisms are involved in modulating large-scale chromatin structure during the final phase of oocyte differentiation.
Asunto(s)
Ensamble y Desensamble de Cromatina/efectos de los fármacos , Oocitos/crecimiento & desarrollo , Folículo Ovárico/crecimiento & desarrollo , Hidrolasas Diéster Fosfóricas/administración & dosificación , Animales , Bovinos , Comunicación Celular/efectos de los fármacos , Ensamble y Desensamble de Cromatina/genética , Células del Cúmulo/citología , Células del Cúmulo/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Desarrollo Embrionario/genética , Femenino , Uniones Comunicantes/efectos de los fármacos , Uniones Comunicantes/genética , Técnicas de Maduración In Vitro de los Oocitos , Meiosis/efectos de los fármacos , Oocitos/citología , Oocitos/efectos de los fármacos , Oogénesis/efectos de los fármacosRESUMEN
The venom of Loxosceles spiders produces severe dermonecrotic damage, intravascular hemolysis, systemic alterations and risk of death. Clostridium perfringens is present in the microbial flora of the fangs and venom glands of Loxosceles intermedia. Its inoculation with the venom may infect the wound site and exacerbate the dermonecrotic damage. This anaerobic bacterium is widely distributed in nature and capable of damage with similar characteristics and severity to the spider venom. In this study we isolated and characterized species of Clostridium from the fangs and venom glands of Loxosceles laeta, including C. perfringens. The sensitivity patterns of different isolates of C. perfringens were evaluated by minimum inhibitory concentration against penicillin, ampicillin, erythromycin, gentamicin, chloramphenicol, clindamycin and tetracycline, under anaerobic conditions, using the method of microdilution in broth. Strain C. perfringens H28 showed resistance to penicillin, ampicillin, tetracycline and chloramphenicol. Resistance to penicillin and ampicillin was mediated by beta-lactamase. In vivo evaluation of dermonecrosis in rabbits using L. laeta venom co-inoculated with isolate C. perfringens H28 produced an increase in the area of dermonecrotic lesions in the presence of penicillin and tetracycline, but not with gentamicin. Antibiotic therapy Loxosceles poisoning should be re-evaluated, considering the existence of multi-resistant strains of C. perfringens.
Asunto(s)
Antibacterianos/farmacología , Clostridium perfringens/aislamiento & purificación , Glándulas Exocrinas/microbiología , Hidrolasas Diéster Fosfóricas/efectos adversos , Picaduras de Arañas/microbiología , Venenos de Araña/efectos adversos , Arañas/microbiología , Diente/microbiología , Animales , Antivenenos/administración & dosificación , Clostridium perfringens/efectos de los fármacos , Clostridium perfringens/patogenicidad , Expresión Génica , Inyecciones Intradérmicas , Masculino , Necrosis/inducido químicamente , Resistencia a las Penicilinas/efectos de los fármacos , Resistencia a las Penicilinas/genética , Penicilinas/farmacología , Hidrolasas Diéster Fosfóricas/administración & dosificación , Hidrolasas Diéster Fosfóricas/análisis , Conejos , Piel/efectos de los fármacos , Picaduras de Arañas/tratamiento farmacológico , Venenos de Araña/administración & dosificación , Venenos de Araña/análisis , Tetraciclina/farmacología , Resistencia a la Tetraciclina/efectos de los fármacos , Resistencia a la Tetraciclina/genética , beta-Lactamasas/metabolismoRESUMEN
Autotaxin, also known as NPP2 (nucleotide pyrophosphatase/phosphodiesterase 2), is a secreted lysophospholipase-D that generates lysophosphatidic acid and thereby promotes the metastatic and invasive properties of tumor cell as well as angiogenesis. We show here that, in mice, NPP2 is cleared from the circulation within minutes and is retained by the liver sinusoidal endothelial cells (LSECs). The binding of NPP2 to isolated LSECs resulted in its degradation and could be competed for with ligands of the scavenger receptor family. Our finding that circulating NPP2 has a rapid turnover has important implications for its development as an anti-cancer target.
Asunto(s)
Células Endoteliales/metabolismo , Hígado/irrigación sanguínea , Complejos Multienzimáticos/farmacocinética , Metástasis de la Neoplasia/fisiopatología , Proteínas de Neoplasias/farmacocinética , Fosfodiesterasa I/farmacocinética , Hidrolasas Diéster Fosfóricas/farmacocinética , Pirofosfatasas/farmacocinética , Receptores Depuradores/metabolismo , Animales , Células Cultivadas/metabolismo , Formaldehído/farmacología , Humanos , Inyecciones Intravenosas , Masculino , Tasa de Depuración Metabólica , Ratones , Complejos Multienzimáticos/administración & dosificación , Complejos Multienzimáticos/sangre , Metástasis de la Neoplasia/prevención & control , Proteínas de Neoplasias/administración & dosificación , Proteínas de Neoplasias/sangre , Proteínas de Neoplasias/fisiología , Fosfodiesterasa I/administración & dosificación , Fosfodiesterasa I/sangre , Hidrolasas Diéster Fosfóricas/administración & dosificación , Hidrolasas Diéster Fosfóricas/sangre , Pirofosfatasas/administración & dosificación , Pirofosfatasas/sangre , Ratas , Ratas Wistar , Receptores Depuradores/antagonistas & inhibidores , Albúmina Sérica Bovina/farmacologíaRESUMEN
Accidents involving Brown spider (Loxosceles sp.) venom produce a massive inflammatory response in injured region. This venom has a complex mixture of different toxins, and the dermonecrotic toxin is the major contributor to toxic effects. The ability of Loxosceles intermedia venom and a recombinant isoform of dermonecrotic toxin to induce edema and increase in vascular permeability was investigated. These toxins were injected into hind paws and caused a marked dose and time-dependent edema and increase in vascular permeability in mice. Furthermore, the enzymatic activity of venom toxins may be primal for these effects. A mutated recombinant isoform of dermonecrotic toxin, that has only residual enzymatic activity, was not able to induce these inflammatory events. Besides the previous heating of toxins markedly reduced the paw edema and vascular permeability showing that thermolabile constituents can trigger these effects. In addition, the ability of these venom toxins to evoke inflammatory events was partially reduced in compound 48/80-pretreated animals, suggesting that mast cells may be involved in these responses. Pretreating mice with histamine (prometazine and cetirizine) and serotonin (methysergide) receptor antagonists significantly attenuated toxins induced edema and vascular permeability. Moreover, HPLC analysis of whole venom showed the presence of histamine sufficient to induce inflammatory responses. In conclusion, these inflammatory events may result from the activation of mast cells, which in turn release bioamines and may be related to intrinsic histamine content of venom.
Asunto(s)
Permeabilidad Capilar/efectos de los fármacos , Edema/inducido químicamente , Fosfolipasa D/toxicidad , Hidrolasas Diéster Fosfóricas/toxicidad , Venenos de Araña/toxicidad , Arañas , Animales , Degranulación de la Célula/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Edema/inmunología , Histamina/análisis , Antagonistas de los Receptores Histamínicos/farmacología , Calor , Inyecciones Subcutáneas , Mastocitos/efectos de los fármacos , Ratones , Mutación , Fosfolipasa D/administración & dosificación , Fosfolipasa D/genética , Fosfolipasa D/aislamiento & purificación , Hidrolasas Diéster Fosfóricas/administración & dosificación , Hidrolasas Diéster Fosfóricas/química , Hidrolasas Diéster Fosfóricas/genética , Desnaturalización Proteica , Proteínas Recombinantes/toxicidad , Serotonina/análisis , Antagonistas de la Serotonina/farmacología , Venenos de Araña/administración & dosificación , Venenos de Araña/química , Venenos de Araña/genética , Venenos de Araña/aislamiento & purificación , Factores de Tiempo , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
Human accidents caused by Loxosceles spiders may result in local dermal necrosis and, in some cases, severe systemic reactions - such as intravascular hemolysis, disseminated intravascular coagulation (DIC), renal failure and death. Since many aspects of envenomation by Loxosceles spiders remain unclear, we studied the hematological and hemostatic responses induced by the i.d. injection of 10 microg/kg Loxosceles gaucho venom in rabbits. For this purpose, total blood cell count, platelet function, coagulation tests and biochemical parameters were analysed at 3, 24, 48, 72 and 120 hours after venom administration. Thrombocytopenia and leukopenia were noted at 3 and 24 hours. Histopathological analysis of the skin lesion, performed at 24 hours after venom administration, showed a massive presence of leukocytes and platelets, hemorrhage and thrombus formation at the injection site. At 72 and 120 hours, neutrophilic leukocytosis and thrombocytosis were observed. Platelet hyperaggregation was noticeable at 48 and 72 hours. Haptoglobin and fibrinogen levels were elevated early and remained in high levels over time. Significant increases in coagulation factors V, VII, VIII, IX, X and XI were noted at 120 hours. The results showed that neither intravascular hemolysis nor DIC occurred. However, the early onset of thrombocytopenia and leukopenia are important findings that may be related to dermal necrosis formation during loxoscelism.
Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Leucopenia/inducido químicamente , Hidrolasas Diéster Fosfóricas/toxicidad , Conejos/sangre , Serina Endopeptidasas/toxicidad , Venenos de Araña/toxicidad , Trombocitopenia/inducido químicamente , Animales , Coagulación Sanguínea/fisiología , Pruebas de Química Clínica , Pruebas Hematológicas , Inyecciones Intradérmicas , Leucopenia/sangre , Leucopenia/patología , Masculino , Hidrolasas Diéster Fosfóricas/administración & dosificación , Serina Endopeptidasas/administración & dosificación , Piel/efectos de los fármacos , Piel/patología , Venenos de Araña/administración & dosificación , Trombocitopenia/sangre , Trombocitopenia/patologíaRESUMEN
It is well known that Loxosceles venom induces local dermonecrosis in rabbits, guinea pigs and humans but not in mice, although, depending on the dose, Loxosceles venom can be lethal to mice. In this work we demonstrate that mice injected intradermally in the dorsal area of the back can survive a lethal dose of Loxosceles gaucho venom and also develop an inflammatory reaction (with infiltration of leukocytes shown by histological analysis) at the local injection site when the venom is co-administered with sphingomyelin. It was observed that more venom was retained for a longer period of time at the local injection site when venom was co-administered with sphingomyelin. The presence of exogenous sphingomyelin did not influence significantly the release of TNF-alpha induced by L. gaucho venom. These results suggest that the action of venom on sphingomyelin, producing ceramide phosphate, causes the development of an inflammatory reaction, which in turn traps the venom in the local area for a long period of time and does not allow it to disperse systemically in a dose sufficient to cause death. Our findings also indicate that the size and availability of the local sphingomyelin pool may be important in determining the outcome of Loxosceles envenoming in different mammalian species.